Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial.

Published

Journal Article (Letter)

Full Text

Cited Authors

  • Tillmann, HL; Kaiser, T; Fox, Z; Staszewski, S; Antunes, F; Monforte, AD; Vernazza, P; Hill, A; Dragsted, UB; Lundgren, JD; MaxCmin1 Trial Group,

Published Date

  • November 1, 2005

Published In

Volume / Issue

  • 40 / 3

Start / End Page

  • 378 - 380

PubMed ID

  • 16249716

Pubmed Central ID

  • 16249716

International Standard Serial Number (ISSN)

  • 1525-4135

Digital Object Identifier (DOI)

  • 10.1097/01.qai.0000180079.60945.a3

Language

  • eng

Conference Location

  • United States